BioLight Life Sciences Ltd. (TLV:BOLT)

BioLight Life Sciences Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	20	25	24	30	53	34
Market Cap Growth	4.93%	4.99%	-19.99%	-42.70%	53.43%	-9.45%
Enterprise Value	16	13	12	5	12	-16
Last Close Price	4.32	5.44	5.20	6.61	11.54	7.55
PE Ratio	-	-	-	-	137.74	-
PS Ratio	192.85	115.64	204.41	478.54	17539.14	1106.27
PB Ratio	0.86	0.82	0.80	0.56	0.86	0.57
P/TBV Ratio	1.02	0.97	0.83	0.57	0.87	0.58
EV/Sales Ratio	150.89	58.93	104.02	86.87	4057.47	-
Debt / Equity Ratio	0.01	0.02	0.00	0.01	0.01	0.02
Asset Turnover	0.00	0.01	0.00	0.00	0	0
Quick Ratio	4.49	6.52	3.73	6.95	15.25	19.99
Current Ratio	4.49	6.94	3.91	7.11	15.38	20.09
Return on Equity (ROE)	-63.48%	-27.60%	-65.45%	-15.09%	-0.56%	-22.10%
Return on Assets (ROA)	-25.14%	-18.71%	-14.72%	-10.65%	-10.27%	-10.19%
Return on Capital (ROIC)	-27.95%	-20.48%	-15.73%	-11.12%	-10.78%	-10.99%
Earnings Yield	-69.57%	-28.20%	-107.88%	-26.03%	0.73%	-39.02%
FCF Yield	-58.51%	-43.52%	-45.57%	-31.75%	-20.20%	-39.35%
Buyback Yield / Dilution	-0.21%	-0.29%	-1.70%	0.41%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.